Sublingual Buprenorphine/Naloxone for Chronic Pain in At-Risk Patients: Development and Pilot Test of a Clinical Protocol

Journal of Opioid Management- United States

doi 10.5055/jom.2012.0137

Full Text

Abstract

Available in

Date

Authors

Publisher

Weston Medical Publishing

Related search

Buprenorphine–naloxone

CMAJ
Medicine
2018English

New Developments in the Management of Opioid Dependence: Focus on Sublingual Buprenorphine–naloxone

Substance Abuse and Rehabilitation
2015English

Pmh69 - Quality of Life According to Responder Rate in Opioid Dependent Adults Receiving Treatment With Buprenorphine Depot Injections (Cam2038) Versus Sublingual Buprenorphine/Naloxone

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Buprenorphine/Naloxone Maintenance Therapy in Patients With Meperidine Use Disorder

International Journal of Basic & Clinical Pharmacology
2017English

Abuse Liability of Intravenous Buprenorphine/Naloxone and Buprenorphine Alone in Buprenorphine-Maintained Intravenous Heroin Abusers

Addiction
MedicinePsychiatryMental Health
2010English

A Clinical Trial Comparing Tapering Doses of Buprenorphine With Steady Doses for Chronic Pain and Coexistent Opioid Addiction

Journal of Addiction Medicine
PsychiatryMental HealthPharmacology
2010English

Sublingual Route During Perioperative and Chronic Pain Management

Journal of Anesthesia & Critical Care: Open Access
2015English

The Impact of Buprenorphine/Naloxone Treatment on HIV Risk Behaviors Among HIV-infected, Opioid-Dependent Patients

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2014English

Estimation of the Effect of Buprenorphine/Naloxone Dosing in Medicaid Opioid-Dependent Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy